赛隆药业
(002898)
| 流通市值：10.17亿 | | | 总市值：17.67亿 |
| 流通股本：1.01亿 | | | 总股本：1.76亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 58,454,477.12 | 32,317,204.83 | 56,544,816.92 | 87,118,672.26 |
| 应收票据及应收账款 | 94,009,929.59 | 99,192,910.19 | 65,966,038.83 | 44,069,802.13 |
| 其中：应收票据 | 12,492,676.01 | 13,544,979.32 | 17,936,960.4 | 15,679,598.91 |
| 应收账款 | 81,517,253.58 | 85,647,930.87 | 48,029,078.43 | 28,390,203.22 |
| 应收款项融资 | 8,629,349.96 | 9,954,332.62 | 9,783,336.67 | 11,202,134.68 |
| 预付款项 | 7,928,824.18 | 9,328,646.52 | 7,616,124.14 | 4,297,382.33 |
| 其他应收款合计 | 5,406,850.84 | 7,633,019.45 | 7,259,187.06 | 10,725,320.45 |
| 存货 | 88,452,119.2 | 82,392,529.77 | 79,231,200 | 88,871,523.55 |
| 一年内到期的非流动资产 | - | - | - | 0 |
| 其他流动资产 | 2,051,195.31 | 1,987,934.55 | 2,556,337.87 | 4,768,613.12 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 274,931,746.2 | 242,806,577.93 | 231,100,641.49 | 256,302,322.01 |
| 非流动资产: | | | | |
| 长期应收款 | 1,634,304.4 | 1,607,160.61 | 1,519,634.92 | 1,546,566.89 |
| 其他非流动金融资产 | 4,900,000 | 4,900,000 | 69,856,009.4 | 69,856,009.4 |
| 投资性房地产 | 18,493,323.76 | 18,594,683.5 | 18,776,484.04 | 18,797,402.98 |
| 固定资产 | 324,764,171.82 | 336,538,999.22 | 343,726,003.74 | 350,245,600.44 |
| 在建工程 | 25,930,790.12 | 6,102,770.21 | 2,689,790.72 | 1,435,946.7 |
| 使用权资产 | 64,505,561.81 | 65,003,145.73 | 343,505.88 | 427,778.2 |
| 无形资产 | 70,269,632.5 | 69,837,382.85 | 68,924,816.38 | 66,996,057.83 |
| 开发支出 | 50,153,934.08 | 46,694,088.04 | 44,999,335.15 | 45,736,772.18 |
| 商誉 | - | - | - | 0 |
| 长期待摊费用 | - | - | - | 0 |
| 递延所得税资产 | 1,282,863.32 | 1,448,276.65 | 1,584,426.87 | 1,959,876.16 |
| 其他非流动资产 | 4,211,936.25 | 2,946,206.21 | 787,095.45 | 539,241.56 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 566,146,518.06 | 553,672,713.02 | 553,207,102.55 | 557,541,252.34 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 841,078,264.26 | 796,479,290.95 | 784,307,744.04 | 813,843,574.35 |
| 流动负债: | | | | |
| 短期借款 | 118,270,858.89 | 99,986,123.06 | 80,013,097.16 | 90,047,819.38 |
| 应付票据及应付账款 | 66,187,220.81 | 58,665,041.86 | 52,170,419.68 | 63,528,990.71 |
| 应付账款 | 66,187,220.81 | 58,665,041.86 | 52,170,419.68 | 63,528,990.71 |
| 预收款项 | 0 | 100,000 | - | 100,000 |
| 合同负债 | 11,943,122.85 | 6,292,406.44 | 10,257,549.94 | 11,531,575.51 |
| 应付职工薪酬 | 5,012,184.33 | 7,831,904.74 | 8,647,626.96 | 8,438,796.17 |
| 应交税费 | 3,142,410.57 | 4,009,103.92 | 2,640,514.94 | 4,940,923.96 |
| 其他应付款合计 | 9,296,201.07 | 10,485,340.88 | 9,912,390.44 | 12,572,658.79 |
| 一年内到期的非流动负债 | 25,582,771.33 | 19,095,512.75 | 24,355,183.68 | 21,957,345.13 |
| 其他流动负债 | 9,599,242.43 | 11,488,630.69 | 12,224,218.45 | 13,892,094.37 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 249,034,012.28 | 217,954,064.34 | 200,221,001.25 | 227,010,204.02 |
| 非流动负债: | | | | |
| 长期借款 | 32,850,000 | 22,950,000 | 22,840,000 | 25,080,000 |
| 租赁负债 | 334,375.62 | 368,474.58 | 37,941.79 | 37,976.18 |
| 长期应付款 | 17,828,175.29 | 8,661,316.37 | 11,162,222.45 | 13,232,338.09 |
| 预计负债 | - | - | - | 0 |
| 递延收益 | 2,734,054.58 | 2,720,530.5 | 2,781,098.67 | 2,841,666.84 |
| 递延所得税负债 | 9,628,942.98 | 9,698,539.1 | 9,759,704.31 | 9,759,704.31 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 63,375,548.47 | 44,398,860.55 | 46,580,967.22 | 50,951,685.42 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 312,409,560.75 | 262,352,924.89 | 246,801,968.47 | 277,961,889.44 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 176,000,000 | 176,000,000 | 176,000,000 | 176,000,000 |
| 资本公积 | 288,469,403.58 | 288,469,403.58 | 288,469,403.58 | 288,469,403.58 |
| 盈余公积 | 18,009,717.23 | 18,009,717.23 | 18,009,717.23 | 18,009,717.23 |
| 未分配利润 | 46,189,582.7 | 51,647,245.25 | 55,026,654.76 | 53,402,564.1 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 528,668,703.51 | 534,126,366.06 | 537,505,775.57 | 535,881,684.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 528,668,703.51 | 534,126,366.06 | 537,505,775.57 | 535,881,684.91 |
| 负债和股东权益合计 | 841,078,264.26 | 796,479,290.95 | 784,307,744.04 | 813,843,574.35 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-20 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |